Solomon Islands
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.082 (0.036–0.15) 15 (6.6–27)
Mortality (HIV+TB only)        
Prevalence  (includes HIV+TB) 0.83 (0.38–1.5) 151 (70–264)
Incidence  (includes HIV+TB) 0.54 (0.44–0.64) 97 (80–116)
Incidence (HIV+TB only)        
Case detection, all forms (%) 67 (57–82)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 157 (44) Relapse 5 (31)
Smear-negative 87 (24) Treatment after failure 5 (31)
Smear-unknown / not done 0 (0) Treatment after default 5 (31)
Extrapulmonary 112 (31) Other 1 (6)
Other 0 (0)      
Total new 356   Total retreatment 16  
           
Other (history unknown) 0        
Total new and relapse 361   Total cases notified 372  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.0 0.9 1.3
Age < 15 8 19 34
Laboratories 2012
Smear (per 100 000 population) 1.5
Culture (per 5 million population) 0
Drug susceptibility testing (per 5 million population) 0
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 90   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 92  
Retreatment 100  
TB/HIV 2012 Number (%)
TB patients with known HIV status 45 (12)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0  
HIV-positive TB patients on antiretroviral therapy (ART) 0  
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 4.9 (3.6–6.1) 0 (0–21)
MDR-TB cases among notified pulmonary
TB cases
12 (9–15) 0 (0–3)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 9 (6%) 16 (100%) 25
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions) 1.3
% Funded domestically 26%
% Funded internationally 74%
% Unfunded 0%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data